Fibroblast Growth Factor 23 and Sclerostin in Relation to Calcium in COVID-19 Patients
Clinical trial NCT05275491 · COMPLETED
Trial details
- NCT number
- NCT05275491
- Sponsor
- Aswan University Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-05-01
- Primary completion
- 2023-01-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.